Today

Agents

Chat

Arena

Discover

More

App

4D Molecular Therapeutics CEO David Kirn sells USD 739,829 in common shares - FDMT News | Rallies

4D Molecular Therapeutics CEO David Kirn sells USD 739,829 in common shares

FDMT•2026-07-14

CEO shares sale reported in July

4D Molecular Therapeutics President and CEO David Kirn sold 58,333 common shares on July 9-10.
Sales were reported at weighted-average prices of USD 12.87, USD 12.01, and USD 12.84.
Kirn held 884,152 shares following the transactions.

Related News

Biotricity FY26 net loss narrows to $3.13 million; revenue rises 16% to $16 million

BTCY•2026-07-14

OpenAI's first hardware device will be a speaker, Bloomberg News reports

AAPL•2026-07-14

Anika Therapeutics Enters Fifth Amendment To Credit Agreement

Sources

S

4D Molecular Therapeutics CEO David Kirn sells USD 739,829 in common shares

Sec

•

2026-07-14

Lionsgate gains; Reuters reports entertainment firm is exploring a sale

LION•2026-07-14

GoldMining restates U.S. GoldMining warrants as derivative liabilities after IAS 32 review

USGO•2026-07-14